EMRO Selected as a '2026 KOSDAQ Rising Star'
EMRO has been named to the '2026 Kosdaq Rising Star' list. Organized by the Korea Exchange (KRX), the 'Kosdaq Rising Star' initiative recognizes and supports listed Kosdaq companies possessing outstanding technological capabilities and growth potential. EMRO has achieved the honor of being named a Rising Star for four consecutive years since 2023.
For more details, please refer to the article below:
Korea Exchange Selects 18 Companies for '2026 Kosdaq Rising Star'
The Korea Exchange (KRX) announced on the 12th that it has selected 18 listed Kosdaq companies with superior technological strength and high growth potential as '2026 Kosdaq Rising Stars.'
Designed to support the mid-to-long-term growth of promising Kosdaq-listed companies, KRX has been running the Rising Star program since 2009. Selection involves rigorous financial reviews and executive interviews. [...] Among the 22 companies designated as Rising Stars last year, 10 companies—including ST Pharm, Lunit, and EMRO—were re-selected this year.